copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
Tick-borne encephalitis - World Health Organization (WHO) Tick-borne encephalitis (TBE) is an important cause of viral infections of the central nervous system in eastern, central, northern and increasingly western European countries, and in northern China, Mongolia, and the Russian Federation Tick-borne encephalitis virus is a member of the family Flaviviridae Approximately 10 000–12 000 clinical cases of tick-borne encephalitis are reported
Tick-borne encephalitis Tick-borne encephalitis (TBE) is an acute viral illness caused by two closely related memberss of the family Flaviviridae The endemic area for tick-borne encephalitis (TBE) spreads from Alsace-Lorraine in the west to Vladivostok and north-eastern regions of China in the east, and from Scandanavia to Italy, Greece and Crimea in the south
Immunization, Vaccines and Biologicals Immunization offers the most effective protection Currently, there are 4 widely used vaccines of assured quality: FSME-Immun and Encepur, manufactured in Austria and Germany respectively, and based on European strains of the virus; and TBE-Moscow and EnceVir, manufactured in the Russian Federation and based on Far-Eastern strains The 4 vaccines are considered to be safe and effective In
Immunization is the best protection against tick-borne encephalitis Immunization offers the most effective protection against tick-borne encephalitis Currently, there are four widely used vaccines of assured quality: FSME-Immun and Encepur, manufactured in Austria and Germany respectively, and TBE-Moscow and EnceVir, manufactured in the Russian Federation The four vaccines are considered to be safe and
Microsoft Word - TBE Grad Table I final. docx 1There are no trials on vaccine efficacy against clinical TBE; indirect evidence of protection is provided by trials using immunogenicity (in this case mainly induction of neutralizing antibodies) as an endpoint These 7 RCTs show strong antibody induction (high seroconversion rates) following TBE vaccination In addition, observational studies regularly demonstrate the strong immunogenicity
Coronavirus disease (COVID-19) COVID-19 is the disease caused by a coronavirus called SARS-CoV-2 WHO first learned of this new virus on 31 December 2019, following a report of a cluster of cases of so-called viral pneumonia in Wuhan, People’s Republic of China
Public health advice on ticks and tick-borne diseases Ticks can transmit diseases that may result in serious short- and long-term illness or even death In the WHO European Region, diseases include Lyme disease or borreliosis, tick-borne encephalitis (TBE), tularemia and Crimean-Congo hemorrhagic fever
Microsoft Word - TBE GradTab III final. doc Evidence that the two Western TBE vaccines induce protective immunity not only against the homologous subtype, but also against the Far Eastern and Siberian subtypes of the virus, is provided by preclinical studies in mice Thus, Holzmann H et al, 1992 found no statistically significant difference in the degree of protection when mice were immunized with European prototype vaccine virus and
Immunization, Vaccines and Biologicals Tick-borne encephalitisThe Immunization, Vaccines and Biologicals department is responsible for targeting vaccine-preventable diseases, guiding immunization research and establishing immunization policy